EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hydroxychloroquine as an Adjunct Therapy for Diabetes in Pregnancy

Nurul Iftida Basri iD, Padma Murthi iD, Rahana Abd Rahman iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25179681 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Nurul Iftida Basri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, National University of Malaysia, Kuala Lumpur 56000, Malaysia. Hauptthemen laut MEDLINE: Hydroxychloroquine, Diabetes, Gestational. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine Fundamental Grant (GFFP) of the National University of Malaysia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review discusses the pathophysiology of diabetes in pregnancy in relation to the placental function. We review the potential use of hydroxychloroquine in improving pregnancy outcomes affected by diabetes. The review focuses on the mechanism of action of hydroxychloroquine and its potential effects on diabetes. There are several pathways in which hydroxychloroquine mediates its effects: through the inflammasome complex, inflammatory cytokines, oxidative stress, modulatory effects, and antihyperglycemic effects. As a safe drug to be used in pregnancy, it is worth exploring the possible use hydroxychloroquine as an adjunct treatment to the current therapy of diabetes in pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydroxychloroquineDiabetes, GestationalHumansPregnancyFemaleOxidative StressPlacentaHypoglycemic AgentsPregnancy Outcome

Stichwörter der Autor:innen

diabeteshydroxychloroquineinflammationplacentapregnancy

Substanzen

HydroxychloroquineHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Faculty of Medicine, National University of Malaysia, Kuala Lumpur 56000, Malaysia.
  • Department of Obstetrics and Gynecology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia.
  • Department of Pharmacology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.

ORCID-Profile: Nurul Iftida Basri, Padma Murthi, Rahana Abd Rahman

Förderung

  • Faculty of Medicine Fundamental Grant (GFFP) of the National University of Malaysia

Zitieren

APA

Basri, N. I., Murthi, P., & Abd Rahman, R. (2024). Hydroxychloroquine as an Adjunct Therapy for Diabetes in Pregnancy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179681

Vancouver

Basri NI, Murthi P, Abd Rahman R. Hydroxychloroquine as an Adjunct Therapy for Diabetes in Pregnancy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179681

BibTeX
@article{Basri2024,
  author = {Basri, Nurul Iftida and Murthi, Padma and Abd Rahman, Rahana},
  title = {Hydroxychloroquine as an Adjunct Therapy for Diabetes in Pregnancy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25179681}
}
Kostenlos starten →